Dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) increases the risk of obesity

André Nguyen Dietzsch,Hadi Al-Hasani,Joachim Altschmied,Katharina Bottermann,Jana Brendler,Judith Haendeler,Susanne Horn,Isabell Kaczmarek,Antje Körner,Kerstin Krause,Kathrin Landgraf,Diana Le Duc,Laura Lehmann,Stefan Lehr,Stephanie Pick,Albert Ricken,Rene Schnorr,Angela Schulz,Martina Strnadová,Akhil Velluva,Heba Zabri,Torsten Schöneberg,Doreen Thor,Simone Prömel

DOI: https://doi.org/10.1038/s41392-024-01810-7

IF: 39.3

2024-04-26

Signal Transduction and Targeted Therapy

Abstract:Obesity is one of the diseases with severe health consequences and rapidly increasing worldwide prevalence. Understanding the complex network of food intake and energy balance regulation is an essential prerequisite for pharmacological intervention with obesity. G protein-coupled receptors (GPCRs) are among the main modulators of metabolism and energy balance. They, for instance, regulate appetite and satiety in certain hypothalamic neurons, as well as glucose and lipid metabolism and hormone secretion from adipocytes. Mutations in some GPCRs, such as the melanocortin receptor type 4 (MC4R), have been associated with early-onset obesity. Here, we identified the adhesion GPCR latrophilin 1 (ADGRL1/LPHN1) as a member of the regulating network governing food intake and the maintenance of energy balance. Deficiency of the highly conserved receptor in mice results in increased food consumption and severe obesity, accompanied by dysregulation of glucose homeostasis. Consistently, we identified a partially inactivating mutation in human ADGRL1/LPHN1 in a patient suffering from obesity. Therefore, we propose that LPHN1 dysfunction is a risk factor for obesity development.

biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problem this paper attempts to address is whether dysfunction of the adhesion G protein-coupled receptor latrophilin 1 (ADGRL1/LPHN1) is related to the occurrence of obesity. Specifically, the researchers aim to verify the role of LPHN1 in regulating food intake and energy balance and to assess whether its dysfunction can lead to obesity.

The background of the study points out that obesity is a disease with serious health consequences and a rapidly increasing global prevalence. Understanding the complex network of food intake and energy balance regulation is crucial for the pharmacological intervention of obesity. G protein-coupled receptors (GPCRs) are one of the main regulators of metabolism and energy balance. They are involved in processes such as regulating appetite and satiety in hypothalamic neurons, glucose and lipid metabolism in adipocytes, and hormone secretion. Mutations in some GPCRs (such as melanocortin 4 receptor, MC4R) are known to be associated with early-onset obesity.

In this study, the authors identified ADGRL1/LPHN1 as a member of the network that regulates food intake and maintains energy balance. By constructing an LPHN1 gene knockout mouse model, the study found that these mice exhibited increased food intake and severe obesity symptoms, accompanied by glucose homeostasis disorders. Additionally, the researchers found a partially inactivating human ADGRL1/LPHN1 mutation in an obese patient, further supporting the hypothesis that LPHN1 dysfunction may be a risk factor for the development of obesity.

In summary, this paper mainly explores the potential role of LPHN1 in the pathogenesis of obesity, providing a new perspective for the prevention and treatment of obesity.